Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

    Luca Stingeni, Andrea Chiricozzi in American Journal of Clinical Dermatology (2024)

  2. Article

    Open Access

    AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

    AtopyReg® is a multicenter, prospective, observational, non-profit cohort study on moderate-to-severe atopic dermatitis in adults promoted in 2018 by the Italian Society of Dermatology and Venereology (SIDeMaST)....

    Luca Stingeni, Andrea Chiricozzi in American Journal of Clinical Dermatology (2024)

  3. Article

    Open Access

    Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

    Andrea Chiricozzi, Michela Ortoncelli in American Journal of Clinical Dermatology (2023)

  4. Article

    Open Access

    Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

    Janus kinase (JAK) inhibitors, including upadacitinib, have been recently approved for the treatment of moderate-severe atopic dermatitis (AD) and real-world data on upadacitinib effectiveness and safety are l...

    Andrea Chiricozzi, Michela Ortoncelli in American Journal of Clinical Dermatology (2023)

  5. Article

    Open Access

    Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials

    Two phase III trials, ECZTRA 1 and 2, confirmed the efficacy and safety of tralokinumab versus placebo in adults with moderate-to-severe atopic dermatitis (AD). To further explore the long-term efficacy of tra...

    Eric L. Simpson, Andrew E. Pink in American Journal of Clinical Dermatology (2023)

  6. Article

    Open Access

    The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients

    Atopic dermatitis (AD) is a common inflammatory chronic skin disease typically associated with atopic comorbidities and other non-atopic conditions such as sleep disturbances, and mood/anxiety disorders. A gro...

    Federico Salfi, Giulia Amicucci, Michele Ferrara in Archives of Dermatological Research (2023)

  7. No Access

    Chapter

    Kaposi’s Sarcoma

    Kaposi’s sarcoma (KS) is a multifocal tumor of lymphatic endothelial cell origin associated with human type 8 herpesvirus (HHV-8). Four variants of KS (classic, endemic African, epidemic HIV-related, and iatro...

    Ketty Peris, Laura Del Regno in European Handbook of Dermatological Treatments (2023)

  8. Article

    Open Access

    Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period

    The complexity of multimodal approaches in cancer management has lately led to the establishment of multidisciplinary tumor boards (MDTBs) to define targeted, patient-centered treatment strategies. However, fe...

    Gustavo Savino, Fabrizio Piccinni, Monica Maria Pagliara in BMC Ophthalmology (2022)

  9. Article

    Open Access

    Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study

    The efficacy and safety of upadacitinib in atopic dermatitis (AD) have been defined in clinical trials, but no real-world data are currently available. We aimed to assess the safety and effectiveness of upadac...

    Andrea Chiricozzi, Niccolò Gori, Alessandra Narcisi, Anna Balato in Drugs in R&D (2022)

  10. Article

    Open Access

    Update on the Management of Pediatric Psoriasis: An Italian Consensus

    Psoriasis affects children with a considerable burden in early life. Treating pediatric psoriasis is challenging also because of the lack of updated specific guidelines. With the recent approval of several bio...

    Ketty Peris, Anna Belloni Fortina, Luca Bianchi in Dermatology and Therapy (2022)

  11. No Access

    Article

    Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family

    While several high-penetrance melanoma risk genes are known, variation in these genes fail to explain melanoma susceptibility in a large proportion of high-risk families. As part of a melanoma family sequencin...

    Kevin M. Brown, Mai Xu, Michael Sargen, Hyunbum Jang, Mingzhen Zhang in Familial Cancer (2022)

  12. Article

    Open Access

    The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review

    Aim of this study was to systematically review the literature to assess efficacy and safety of stereotactic radiotherapy (SRT) in combination with immunotherapy for the treatment of melanoma brain metastases (...

    Valentina Lancellotta, Laura Del Regno, Alessandro Di Stefani in La radiologia medica (2022)

  13. Article

    Open Access

    Correction to: A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions

    Laura Del Regno, Silvia Catapano in American Journal of Clinical Dermatology (2022)

  14. Article

    Open Access

    A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions

    Actinic keratosis (AK) is a chronic skin disease in which clinical and subclinical cutaneous lesions coexist on sun-exposed areas such as the head and neck region and the extremities. The high prevalence of AK...

    Laura Del Regno, Silvia Catapano in American Journal of Clinical Dermatology (2022)

  15. Article

    Open Access

    Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study

    The efficacy of biological therapies used for the treatment of chronic plaque psoriasis can be influenced by numerous variables including  body mass index (BMI).

    Federico Pirro, Giacomo Caldarola, Andrea Chiricozzi in Clinical Drug Investigation (2021)

  16. Article

    Open Access

    A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study

    Psoriasis is a chronic immune-mediated inflammatory skin disease which can also involve joints. It is often associated with burdensome comorbidities which negatively impact prognosis and quality of life (QoL)....

    Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini in BMC Health Services Research (2021)

  17. No Access

    Article

    Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study

    The objective of this study was to assess the effectiveness and safety of dupilumab in treating elderly patients with atopic dermatitis from baseline to 52 weeks.

    Cataldo Patruno, Gabriella Fabbrocini in American Journal of Clinical Dermatology (2021)

  18. Article

    Open Access

    Molecular alterations in basal cell carcinoma subtypes

    A number of genes have been implicated in the pathogenesis of BCC in addition to the Hedgehog pathway, which is known to drive the initiation of this tumour. We performed in-depth analysis of 13 BCC-related ge...

    Lucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani in Scientific Reports (2021)

  19. Article

    Open Access

    Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations

    Treat-to-target strategies are used in several chronic diseases to improve outcomes. Treatment goals have also been suggested for psoriasis, but there is currently no consensus on targets, and guidance is need...

    Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi in Dermatology and Therapy (2021)

  20. Article

    The impact of the COVID-19 pandemic on dermatologic practice: an Italian survey

    Since December 2019, the global population has been experiencing an unprecedented challenge due to Corona virus disease (COVID-19). A pandemic was declared by the World Health Organization on March 11th 2020, wit...

    Martina Lambertini, Annalisa Patrizi, Ketty Peris in European Journal of Dermatology (2021)

previous disabled Page of 3